Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,148 public trials 1,871 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Completed

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

NCT01346540

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1199.82.39004 Boehringer Ingelheim Investigational Site Milan, Italy
  • 1199.82.3102 Boehringer Ingelheim Investigational Site Maastricht, Netherlands
  • 1199.82.3401 Boehringer Ingelheim Investigational Site Barcelona, Spain
  • 1199.82.3406 Boehringer Ingelheim Investigational Site Madrid, Spain
View Trial Details
Completed

Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers

NCT04230408

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • INCA Rio de Janeiro, Brazil
  • Liga Norte Riograndense Contra o Câncer Natal, Rio Grande do Norte, Brazil
  • CPO Porto Alegre, Rio Grande do Sul, Brazil
  • COI Américas Rio de Janeiro, Brazil
View Trial Details
Completed

Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy

NCT02300298

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1199.90.81001 Boehringer Ingelheim Investigational Site Chiba , Kashiwa, Japan
  • 1199.90.81003 Boehringer Ingelheim Investigational Site Kanagawa, Yokohama, Japan
  • 1199.90.81007 Boehringer Ingelheim Investigational Site Osaka, Osakasayama, Japan
  • 1199.90.81006 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan
View Trial Details
Completed

Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2

NCT02733159

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • Southampton University Hospitals NHS Trust Southampton, Hampshire, United Kingdom
  • Maidstone and Tunbridge Wells NHS Trust Maidstone, Kent, United Kingdom
  • University Hospital Birmingham NHS Foundation Trust Birmingham, West Midlands, United Kingdom
View Trial Details
Completed

Comparison of Efficacy and Safety of Tislelizumab (BGB-A317) Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With Non-Small Cell Lung Cancer (NSCLC)

NCT03358875

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital de Amor Barretos Barretos, Brazil
  • Hospital Evangelico de Cachoeiro de Itapemirim Cachoeiro de Itapemirim, Brazil
  • Hospital Haroldo Juacaba Instituto Do Cancer Do Ceara Fortaleza, Brazil
  • Oncosite Centro de Pesquisa Clinica Em Oncologia Ijuí, Brazil
View all 121 locations
View Trial Details
Completed

A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

NCT03532880

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Baptist Alliance Miami Cancer Institute Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Completed

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

NCT02349412

Conditions
Adenoma, Anxiety Disorder, Anxiety Disorders, +48 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Queen's Medical Center Honolulu, Hawaii, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
View all 23 locations
View Trial Details
Completed

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

NCT01638533

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details

Related conditions